New anti-reflux plastic stent to reduce the risk of stent-related cholangitis in the treatment of biliary strictures

Xiang-Lei Yuan,Lian-Song Ye,Xian-Hui Zeng,Qing-Hua Tan,Yi Mou,Wei Liu,Chun-Cheng Wu,Hang Yang,Bing Hu
DOI: https://doi.org/10.3748/wjg.v27.i28.4697
IF: 5.374
2021-07-28
World Journal of Gastroenterology
Abstract:There is little data available on the role of new anti-reflux plastic stents (ARPSs).To compare the use of ARPSs with that of traditional plastic stents (TPSs) for patients with biliary strictures.Consecutive patients with biliary strictures who underwent first endoscopic biliary stenting between February 2016 and May 2019 were included. The onset of stent-related cholangitis, stent patency, clinical success, and other adverse events were evaluated.Sixty-seven patients in the ARPS group and 66 patients in the TPS group were included in the final analyses. Fewer patients experienced stent-related cholangitis in the ARPS group than that in the TPS group (8 patients 18 patients; = 0.030). The median time till the onset of first stent-related cholangitis was later in the ARPS group than that in the TPS group (128.5 d 76 d; = 0.039). The cumulative median stent patency in the ARPS group was 185 d, which was significantly longer than that in the TPS group (133 d; = 0.001). The clinical success rates and other adverse events did not significantly differ between both groups.Placement of new ARPS might be a safe and effective optional therapeutic strategy to reduce the risk of stent-related cholangitis and prolong stent patency.
gastroenterology & hepatology
What problem does this paper attempt to address?